Litcius/Paper detail

EGFR forms ligand-independent oligomers that are distinct from the active state

Patrick O. Byrne, Kalina Hristova, Daniel J. Leahy

2020Journal of Biological Chemistry43 citationsDOIOpen Access PDF

Abstract

The human epidermal growth factor receptor (EGFR/ERBB1) is a receptor tyrosine kinase (RTK) that forms activated oligomers in response to ligand. Much evidence indicates that EGFR/ERBB1 also forms oligomers in the absence of ligand, but the structure and physiological role of these ligand-independent oligomers remain unclear. To examine these features, we use fluorescence microscopy to measure the oligomer stability and FRET efficiency for homo- and hetero-oligomers of fluorescent protein-labeled forms of EGFR and its paralog, human epidermal growth factor receptor 2 (HER2/ERBB2) in vesicles derived from mammalian cell membranes. We observe that both receptors form ligand-independent oligomers at physiological plasma membrane concentrations. Mutations introduced in the kinase region at the active state asymmetric kinase dimer interface do not affect the stability of ligand-independent EGFR oligomers. These results indicate that ligand-independent EGFR oligomers form using interactions that are distinct from the EGFR active state.

Topics & Concepts

OligomerLigand (biochemistry)Epidermal growth factor receptorReceptor tyrosine kinaseEpidermal growth factorTyrosine kinaseChemistryFörster resonance energy transferReceptorBiophysicsBiochemistryBiologyCell biologyFluorescencePhysicsQuantum mechanicsOrganic chemistryMonoclonal and Polyclonal Antibodies ResearchHER2/EGFR in Cancer ResearchCell Adhesion Molecules Research